Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/31676
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 18074/20272 (89%)
造访人次 : 4076966      在线人数 : 968
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/31676


    標題: Prognostic Performance of a NewStaging Category to Improve Discrimination of Disease-Specific Survival in Nonmetastatic Oral Cancer
    作者: Lee, Ching-Chih
    Huang, Chien-Yu
    Lin, Yaoh-Shinag
    Chang, Kuo-Ping
    Chi, Chao-Chuan
    Lin, Ming-Yee
    Su, Hsing-Hao
    Chang, Ting-Shou
    Chen, Hung-Chih
    Yang, Ching-Chieh
    貢獻者: Kaohsiung Vet Gen Hosp, Dept Otolaryngol Head & Neck Surg
    Natl Def Med Ctr, Sch Med
    Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg
    Kaohsiung Vet Gen Hosp, Dept Stomatol
    Chi Mei Med Ctr, Dept Radiat Oncol
    Natl Sun Yat Sen Univ, Inst Biomed Sci
    Chia Nan Univ Pharm & Sci, Dept Biotechnol
    關鍵字: Squamous-Cell Carcinoma
    To-Lymphocyte Ratio
    Lung-Cancer
    Neck-Cancer
    N3 Head
    Neutrophil
    Inflammation
    Induction
    Resection
    Site
    日期: 2017-04
    上傳時間: 2018-11-30 15:52:30 (UTC+8)
    出版者: Amer Medical Assoc
    摘要: IMPORTANCE Inflammatory status is associated with outcome in oral squamous cell carcinoma (OSCC). Combining the preoperative neutrophil to lymphocyte ratio (NLR) and histopathologic featuresmay provide clinicians with more exact information regarding the prognosis of OSCC. OBJECTIVE To compare the prognostic performance of the routinely used pathologic TNM staging with a new staging category that incorporates the NLR and histopathologic features. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study included 396 patients with newly diagnosed OSCC who underwent major surgery at a medical center from January 1, 2006, through December 31, 2013. Follow-up was completed on October 31, 2015, and data analysis was performed from January 1, 2016, through April 30, 2016. MAIN OUTCOMES AND MEASURES The multivariate Cox proportional hazards regression model was used to determine the clinical or pathologic factors associated with 5-year disease-specific survival (DSS), and these factors were assigned integer points to create a new staging category. The monotonicity and discriminatory ability of the pathologic TNM staging and new staging category were evaluated with the linear trend chi(2) test, Akaike information criterion, and Harrell C statistic. RESULTS In total, 396 patients who underwent major surgery with curative intent for OSCC with or without adjuvant therapy were included in this study (mean [SD] age, 53 [11] years; 367 men [92.7%] and 29 women [7.3%]). Perineural invasion (adjusted hazard ratio [aHR], 1.74; 95% CI, 1.23-2.46), high NLR (aHR, 1.60; 95% CI, 1.11-2.30), advanced pT (T3 + T4) classification (aHR, 1.59; 95% CI, 1.13-2.25), and advanced pN (N2) classification (aHR, 3.96; 95% CI, 2.78-5.63) were independent prognostic survival factors. The beta coefficients from the Cox proportional hazards regression model were used to develop an integer-based weighted point system (perineural invasion, score of 1; NLR, score of 1; advanced pT, score of 1; and advanced pN, score of 3). The summations of these risk scores were stratified for the new staging category as follows: new stage I, score of 0; new stage II, score of 1; new stage III, score of 2 or 3; and new stage IV, score of 4 to 6. Compared with the American Joint Committee on Cancer staging category, this new staging category provided better monotonicity with a higher linear trend chi(2) value (106 vs 49), better discriminatory ability with smaller Akaike information criterion (1497 vs 1533), and greater Harrell C statistic (0.73 vs 0.69) for 5-year DSS. The results remained robust after adjusting other risk factors. CONCLUSIONS AND RELEVANCE In this study, new staging category had better DSS discriminatory ability and could help to identify high-risk patients for intense adjuvant therapy.
    關聯: Jama Otolaryngology-Head & Neck Surgery, v.143, n.4, pp.395-402
    显示于类别:[生物科技系(所)] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML1307检视/开启


    在CNU IR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈